Search Orphan Drug Designations and Approvals
-
Generic Name: | Trans-Cinnamic Acid |
---|---|
Date Designated: | 02/03/2021 |
Orphan Designation: | Treatment of Krabbe disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Polaryx Therapeutics, Inc. 140 E. Ridgewood Avenue, Suite 415, South Tower Paramus , New Jersey 07652 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-